Trevi Therapeutics Signs License Agreements to use Nalbuphine for the Treatment in Parkinson’s Disease
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated…